RPRX

Royalty Pharma plc

Pharmaceutical Preparations · SIC 2834CIK 1802768Held by 9 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:X LINKEDIN EMAIL

9 managers · Q2 2026 13F

13F bookWeight

Dorsey Asset Management

Pat DorseyPosition history →

8.8%

+7.9%

$137.7M

$1.56B13F book · 2026-06-30

Patient Capital Management

Samantha McLemorePosition history →

6.7%

(1.2%)

$201.8M

$3.01B13F book · 2026-06-30

Torray Funds

TorrayPosition history →

4.6%

(6.7%)

$33.8M

$0.74B13F book · 2026-06-30

Adage Capital Management

Adage Capital ManagementPosition history →

0.20%

(66.6%)

$140.2M

$71.32B13F book · 2026-06-30

Renaissance Technologies

Renaissance TechnologiesPosition history →

0.15%

+144.7%

$108.5M

$72.62B13F book · 2026-06-30

Alps Advisors

Alps AdvisorsPosition history →

0.08%

(36.5%)

$17.7M

$21.33B13F book · 2026-06-30

Capital World Investors

Capital World InvestorsPosition history →

0.06%

+18.4%

$533.6M

$846.43B13F book · 2026-06-30

Bridgewater Associates

Bridgewater AssociatesPosition history →

0.05%

NEW

$12.3M

$24.38B13F book · 2026-06-30

Holocene Advisors

Holocene AdvisorsPosition history →

<0.01%

(47.3%)

$0.3M

$43.69B13F book · 2026-06-30

Weight = position value ÷ the manager's total 13F long-equity value in the same filing — one definition for every row. “1st obs.” marks a position with no earlier stored 13F to compare against — it is not shown as a purchase.